NCT06098495 Looking for a Blood Epigenetic Signature to Predict Female Infertility
| NCT ID | NCT06098495 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Università Vita-Salute San Raffaele |
| Condition | Female Infertility |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,456 participants |
| Start Date | 2023-10-16 |
| Primary Completion | 2026-10-16 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,456 participants in total. It began in 2023-10-16 with a primary completion date of 2026-10-16.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The present research project aims to study the DNAm mechanisms underlying the reduction of fertility due to the progressive depletion of oocyte quality. Specifically, our project aims to build an epigenetic clock for MGCs by using outcomes that are certainly related to female fertility. The validation of such findings will be carried out on peripheral blood in order to guarantee its non-invasiveness and allow for any clinical transferability. In order to identify a blood epigenetic signature able to predict female infertility, we planned to explore the problem from different points of view by conducting several studies in different settings.
Eligibility Criteria
Inclusion Criteria: * 18\< age \<43, Infertile woman undergoing ART, recurrent pregnancy loss Exclusion Criteria: * age \< 18 or \> 44, previous ovarian surgery, severe male factor infertility
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06098495 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 43 Years, studying Female Infertility. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06098495 currently recruiting?
Yes, NCT06098495 is actively recruiting participants. Contact the research team at vanni.valeria@hsr.it for enrollment information.
Where is the NCT06098495 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT06098495 clinical trial?
NCT06098495 is sponsored by Università Vita-Salute San Raffaele. The trial plans to enroll 1,456 participants.